CBColin David Bingle

Colin David Bingle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Colin David Bingle has a total of 526 co-authors. Here are the top co-authors by number of shared publications:

  • Lynne Bingle

    Academic Unit of Oral and Maxillofacial Pathology, School of Clinical Dentistry, University of Sheffield, Sheffield, UK

    29 shared publications
  • Lynne Bingle

    Oral and Maxillofacial Pathology, Department of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UK

    11 shared publications
  • Stephen A. Renshaw

    The Bateson Centre, School of Medicine and Population Health, University of Sheffield 2 , Sheffield S10 2TN

    8 shared publications
  • Apoorva Mulay

    Academic Unit of Respiratory Medicine, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK

    6 shared publications
  • Frances A. Barnes

    Academic Unit of Respiratory Medicine, Department of Infection and Immunity, University of Sheffield, Sheffield S10 2JF, UK

    6 shared publications
  • Kirsty Wilson

    Academic Unit of Respiratory Medicine, Dept. of Infection and Immunity University of Sheffield, Sheffield, United Kingdom

    6 shared publications

Latest Publications

  • Open Access

    Does Localisation of BPIFB4 Support Its Proposed Function in Extending Healthy Longevity?

    by Colin Bingle, Leon Maudgil, Oluwatimilehin Babajide

    In 2015 a polymorphic variant of Bactericidal/permeability-increasing protein (BPI) Fold containing Family B Member 4 (BPIFB4) was genetically associated with longevity. Following on from this intriguing observation, a literature has developed that suggests that this poorly characterised secreted protein, plays a pleiotropic role in maintaining human health and extending lifespan. In this article we briefly review what is known about BPIFB4 and discuss how its sites of expression may impact on these proposed functions.

  • Open Access

    Artificial intelligence

    by Colin D. Bingle

    Welcome, to the May edition of the Biochemist with its focus on artificial intelligence (AI). It appears that not a week goes by when AI is not in the

  • Open Access

    Psychedelic therapies

    by Colin Bingle

    It is my great pleasure to introduce the first issue of The Biochemist to you for 2024. This represents my first issue as Science Editor, having taken

  • Open Access

    Respiratory epithelial cell types, states and fates in the era of single-cell RNA-sequencing

    by Oleksandr Dudchenko, Jose Ordovas-Montanes, Colin D. Bingle

    Standalone and consortia-led single-cell atlases of healthy and diseased human airways generated with single-cell RNA-sequencing (scRNA-seq) have ushered in a new era in respiratory research. Numerous discoveries, including the pulmonary ionocyte, potentially novel cell fates, and a diversity of cell states among common and rare epithelial cell types have highlighted the extent of cellular heterogeneity and plasticity in the respiratory tract. scRNA-seq has also played a pivotal role in our understanding of host–virus interactions in coronavirus disease 2019 (COVID-19). However, as our ability to generate large quantities of scRNA-seq data increases, along with a growing number of scRNA-seq protocols and data analysis methods, new challenges related to the contextualisation and downstream applications of insights are arising. Here, we review the fundamental concept of cellular identity from the perspective of single-cell transcriptomics in the respiratory context, drawing attention to the need to generate reference annotations and to standardise the terminology used in literature. Findings about airway epithelial cell types, states and fates obtained from scRNA-seq experiments are compared and contrasted with information accumulated through the use of conventional methods. This review attempts to discuss major opportunities and to outline some of the key limitations of the modern-day scRNA-seq that need to be addressed to enable efficient and meaningful integration of scRNA-seq data from different platforms and studies, with each other as well as with data from other high-throughput sequencing-based genomic, transcriptomic and epigenetic analyses.


  • Open Access

    Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children

    by André G. Costa-Martins, Karim Mane, Benjamin B. Lindsey, Rodrigo L.T. Ogava, I′Caro Castro, Ya Jankey Jagne, Hadijatou J. Sallah, Edwin P. Armitage, Sheikh Jarju, Bankole Ahadzie, et al.

  • SPLUNC1 comes of age? Predicting acute exacerbations in cystic fibrosis

    by Colin D. Bingle, Lynne Bingle

    Measurement of the levels of SPLUNC1 in sputum may be a useful biomarker of cystic fibrosis exacerbationshttps://bit.ly/2TBfaB9

  • Open Access

    De novo identification of mammalian ciliary motility proteins using cryo-EM

    by Miao Gui, Hannah Farley, Priyanka Anujan, Jacob R. Anderson, Dale W. Maxwell, Jonathan B. Whitchurch, J. Josephine Botsch, Tao Qiu, Shimi Meleppattu, Sandeep K. Singh, et al.


  • Open Access

    The transcriptional landscape of the cultured murine middle ear epithelium in vitro

    by Apoorva Mulay, Miraj K. Chowdhury, Cameron T. James, Lynne Bingle, Colin D. Bingle

    Otitis media (OM) is the most common paediatric disease and leads to significant morbidity. Although understanding of underlying disease mechanisms is hampered by complex pathophysiology, it is clear that epithelial abnormalities underpin the disease. The mechanisms underpinning epithelial remodelling in OM remain unclear. We recently described a novel in vitro model of mouse middle ear epithelial cells (mMEECs) that undergoes mucociliary differentiation into the varied epithelial cell populations seen in the middle ear cavity. We now describe genome wide gene expression profiles of mMEECs as they undergo differentiation. We compared the gene expression profiles of original (uncultured) middle ear cells, confluent cultures of undifferentiated cells and cells that had been differentiated for 7 days at an air liquid interface (ALI). >5000 genes were differentially expressed among the three groups of cells. Approximately 4000 genes were differentially expressed between the original cells and day 0 of ALI culture. The original cell population was shown to contain a mix of cell types, including contaminating inflammatory cells that were lost on culture. Approximately 500 genes were upregulated during ALI induced differentiation. These included some secretory genes and some enzymes but most were associated with the process of ciliogenesis. The data suggest that the in vitro model of differentiated murine middle ear epithelium exhibits a transcriptional profile consistent with the mucociliary epithelium seen within the middle ear. Knowledge of the transcriptional landscape of this epithelium will provide a basis for understanding the phenotypic changes seen in murine models of OM.


  • Open Access

    TrkB-Targeted Therapy for Mucoepidermoid Carcinoma

    by Vivian P. Wagner, Manoela D. Martins, Esra Amoura, Virgilio G. Zanella, Rafael Roesler, Caroline B. de Farias, Colin D. Bingle, Pablo A. Vargas, Lynne Bingle

    The brain-derived neurotrophic factor (BDNF)/tyrosine receptor kinase B (TrkB) pathway was previously associated with key oncogenic outcomes in a number of adenocarcinomas. The aim of our study was to determine the role of this pathway in mucoepidermoid carcinoma (MEC). Three MEC cell lines (UM-HMC-2, H253 and H292) were exposed to Cisplatin, the TrkB inhibitor, ANA-12 and a combination of these drugs. Ultrastructural changes were assessed through transmission electron microscopy; scratch and Transwell assays were used to assess migration and invasion; and a clonogenic assay and spheroid-forming assay allowed assessment of survival and percentage of cancer stem cells (CSC). Changes in cell ultrastructure demonstrated Cisplatin cytotoxicity, while the effects of ANA-12 were less pronounced. Both drugs, used individually and in combination, delayed MEC cell migration, invasion and survival. ANA-12 significantly reduced the number of CSC, but the Cisplatin effect was greater, almost eliminating this cell population in all MEC cell lines. Interestingly, the spheroid forming capacity recovered, following the combination therapy, as compared to Cisplatin alone. Our studies allowed us to conclude that the TrkB inhibition, efficiently impaired MEC cell migration, invasion and survival in vitro, however, the decrease in CSC number, following the combined treatment of ANA-12 and Cisplatin, was less than that seen with Cisplatin alone; this represents a limiting factor.


  • Expression and function of murine WFDC2 in the respiratory tract

    by Lynne Bingle, Hannah Armes, Colin Bingle

    Whey-acidic-protein (WAP) four-disulfide core domain protein 2 (WFDC2) is one of >15 paralogous genes found in a single locus on chromosome 20 (in man) and 2 (in mice). Members of the WFDC family all contain at least one WFDC structural domain and because the best studied member of this family, secretory leucocyte protease inhibitor (SLPI) has a host defence role it is assumed that WFDC2 also functions in this way. WFDC2 is highly expressed in the respiratory tract and is over-expressed in cystic fibrosis, a lung disease characterized by impairments in host defence. In this study we investigated the expression and function of WFDC2 in the mouse. Transcriptional analysis shows that wfdc2 exhibits a limited tissue distribution, with highest expression in tissues of the respiratory tract and the nasal cavity. Analysis of differentiated mTEC and mNEC shows that wfdc2 is the most highly expressed of the 16 wfdc genes found on chromosome 2 (with slpi being the next highest). Recombinant mWFDC2 was purified from HEK cells and utilised for functional assays. WFDC2 was unable to inhibit the growth of multiple bacterial strains and was not able to inhibit protease activity. Unexpectedly, wfdc2-/- mice died shortly after birth as a result of respiratory distress while heterozygous animals survived to adulthood with no obvious phenotype. MicroCT analysis showed that the trachea and bronchi of wfdc2-/- embryos were constricted. Our data shows that WFDC2, the most abundantly expressed wfdc family member in the respiratory tract, is not a host defence protein and is instead involved in the development of the tracheal and bronchial airways during embryogenesis. The role of WFDC2 in lung development requires further analysis.